Want to track TRVI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Trevi Therapeutics Inc. (TRVI) Statistics
Valuation metrics
Market Cap 2.54B
Enterprise value 2.69B
Trailing P/E (ttm) -59.19
Forward P/E -
PEG ratio -1.67
Price/Sales (ttm) -
Price/Book (mrq) 16.13
Enterprise Value/Revenue -
Enterprise Value/EBITDA -59.04
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.93M
Average volume (90 days) 2.01M
Price summary
52-Week low 6.55
52-Week high 20.22
Beta -
50-Day moving average 17.37
200-Day moving average 12.66
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.25%
Return on equity -0.25%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.31
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.18
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 24.75%
Book value per share (mrq) 1.18
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
